De Lisle Partners LLP Takes $1.92 Million Position in Kewaunee Scientific Corporation $KEQU

De Lisle Partners LLP acquired a new position in Kewaunee Scientific Corporation (NASDAQ:KEQUFree Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 52,626 shares of the technology company’s stock, valued at approximately $1,919,000.

Several other large investors have also added to or reduced their stakes in the business. Minerva Advisors LLC grew its position in Kewaunee Scientific by 51.8% in the fourth quarter. Minerva Advisors LLC now owns 121,863 shares of the technology company’s stock valued at $4,559,000 after purchasing an additional 41,589 shares in the last quarter. Punch & Associates Investment Management Inc. increased its stake in Kewaunee Scientific by 61.9% in the 3rd quarter. Punch & Associates Investment Management Inc. now owns 70,085 shares of the technology company’s stock valued at $2,989,000 after buying an additional 26,785 shares during the last quarter. Northeast Investment Management bought a new stake in Kewaunee Scientific during the 4th quarter worth about $748,000. Susquehanna International Group LLP bought a new stake in Kewaunee Scientific during the 3rd quarter worth about $713,000. Finally, BlackRock Inc. bought a new stake in Kewaunee Scientific during the 2nd quarter worth about $425,000. Institutional investors and hedge funds own 32.69% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “hold (c)” rating on shares of Kewaunee Scientific in a report on Tuesday, June 30th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat, Kewaunee Scientific has a consensus rating of “Hold”.

Check Out Our Latest Stock Report on Kewaunee Scientific

Kewaunee Scientific Price Performance

Shares of KEQU opened at $37.07 on Friday. The company has a market cap of $106.39 million, a price-to-earnings ratio of 11.51 and a beta of 0.72. Kewaunee Scientific Corporation has a 1-year low of $33.27 and a 1-year high of $60.89. The company’s fifty day simple moving average is $36.53 and its 200 day simple moving average is $37.45. The company has a current ratio of 2.18, a quick ratio of 1.55 and a debt-to-equity ratio of 0.53.

Kewaunee Scientific (NASDAQ:KEQUGet Free Report) last announced its quarterly earnings results on Tuesday, June 23rd. The technology company reported $1.14 EPS for the quarter. The firm had revenue of $71.40 million during the quarter. Kewaunee Scientific had a net margin of 3.41% and a return on equity of 14.10%. During the same quarter in the prior year, the business earned $1.95 EPS.

About Kewaunee Scientific

(Free Report)

Kewaunee Scientific Corporation (NASDAQ:KEQU) is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.

The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.

Featured Stories

Want to see what other hedge funds are holding KEQU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kewaunee Scientific Corporation (NASDAQ:KEQUFree Report).

Institutional Ownership by Quarter for Kewaunee Scientific (NASDAQ:KEQU)

Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.